Matt Rieke

Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009.

BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA.

NB Therapeutics, Inc. develops pharmacologic therapies. The firm has two technology platforms: iontophoresis and nitric oxide gas, through these two technology platforms it seeks to address the inherent challenges of drug delivery for diseases of the skin and nails. The company was founded by Frank J. McCaney in 2006 and is headquartered in Bristol, PA.

Novitas Capital Management (Novitas Capital) is a venture capital firm founded in 1997. The firm is headquartered in Wayne, Pennsylvania.

TransEnterix is advancing the field of minimally invasive surgery through exploration, innovation and collaboration. Based in North Carolina's Research Triangle Park, TransEnterix is a rapidly growing medical device company founded in 2006. Since its inception the company has designed, received FDA approval and launched the groundbreaking SPIDER Surgical System, which provides surgeons with enhanced capabilities by creating triangulation via single site access with flexible articulating instruments. The platform enables a whole new class of less invasive surgery - Flexible Laparoscopy - which builds on the proven technologies of laparoscopic surgery and catheter based medical treatments.

Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA.

TearScience, Inc. diagnoses and treats meibomian gland dysfunction. It offers Lipiflow, Lipiscan, and Lipiview. The company was founded by Donald R. Korb and Timothy R. Willis in 2005 and is headquartered in Morrisville, NC.